内镜下套扎术预防肝硬化食管静脉曲张破裂出血的远期随访观察

目的 观察肝硬化食管静脉曲张患者分别行食管静脉曲张套扎术(endoscopic variceal ligation,EVL)和口服普萘洛尔后的再出血发生率、死亡率、治疗前后静脉曲张程度以及肝功能分级变化.方法 共纳入患者118例,其中66例采用EVL治疗,52例采用药物预防治疗.EVL 治疗组给予多次套扎,直到曲张静脉消失;药物治疗组给予普萘洛尔,起始剂量10 mg,每日2次,逐渐增至最大耐受剂量.对所有患者随访20个月,观察比较两组出血发生率和死亡率、治疗前后静脉曲张程度以及肝功能分级变化.结果 EVL治疗组有效随访58例,其问发生出血7例(12.1%),死亡2例(3.4%);药物治疗组有效随访46例,期间发生出血14例(30.4%),死亡6例(13.0%),两组间差异有统计学意义(P<0.05).EVL治疗组总静脉消失率为41.3%(24/58),药物治疗组46例曲张静脉均未消失;比较两组治疗前后肝功能未见明显变化(P>0.05).结论 与服用普萘洛尔相比,EVL能显著降低出血率、死亡率和静脉曲张程度,且对肝功能无明显损害作用.

Long-term follow-up for prophylaxis of esophageal variceal bleeding in patients with hepatic cirrhosis after endoscopic variceal ligation

Objective To investigate the esophageal variceal bleeding,mortality,degree of varices and changes of liver function in patients with hepatic cirrhosis Who underwent endoscopic varieeal ligation (EVL) or received propranolol therapy.Methods One hundred and eighteen patients received either EVL (n=66) or propranolol therapy(n=52).The patients in EVL group were treated with EVL for several times untill varicose vein disappeared.However,the patients in propranolol group received 10 mg of propranolol twice daily at the beginning of treatment.and it was increased to maximum tolerated dose gradually.All patients were followed up for 20 months.The bleeding rate, mortality,improvement of varicose vein and changes of hepatic function before and after treatment were compared between two groups.Results Among 58 patients in EVL group,bleeding was found in 7(12.1%) patients,and 2(3.4%) patients died.Whereas in propranolol group bleeding was found in 14(30.4%) of 46 patients and 6(13%) patients died.There was significant difference between EVL group and propranolol group (P<0.05).Forty one point three percent (24/58) of varicose vein vanished in EVL group,but no varicose vein vanished in propranolol group.There was no significant change of hepatic function before and after treatment between two groups (P>0.05).Conclusions Compared with propranolol therapy,EVL has advantages in decreasing bleeding and mortality as well as improving the degree of varicose vein without liver damage.